183 Results for "

ADC payload

" in MedChemExpress (MCE) Product Catalog:
Products (183)

183 Results for "ADC payload" in MCE Product Catalog:

Cat. No.: HY-186048
CAS No.: 1639428-78-6
Research Areas:  

Infection

MC-VC-PAB-Daptomycin (Compound 54) is the linker-payload of an antibody-drug conjugate (ADC). β-Glucuronide-dPBD-PEG6-NH2 is composed of Daptomycin (HY-13631), a lipopeptide antibiotic, and the linker .
loading...
    loading...
Cat. No.: HY-128952G
CAS No.: 1595275-62-9
Synonyms: SG3249 (GMP)
Tesirine (GMP) (SG3249 (GMP)) is Tesirine (HY-128952) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Tesirine (SG3249) is an antibody-drug conjugate (ADC) pyrrolobenzodiazepine (PBD) dimer payload. Tesirine combines potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. SG3199 (HY-101161) is the released warhead component of the ADC payload Tesirine. SG3199 retains picomolar activity in a panel of cancer cell lines. PBD dimers are highly efficient DNA minor groove cross-linking agents with potent cytotoxicity .
loading...
    loading...
Cat. No.: HY-176478
Target:  

ADC Linkers

Research Areas:  

Cancer

PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC is an ADC linker that can be combined with the TLR7/8 agonist (HY-170770) for the synthesis of a linker-payload conjugate .
loading...
    loading...
Cat. No.: HY-164787
CAS No.: 1448364-29-1
Research Areas:  

Cancer

N-MeVal-Val-Dil-Dap-2-(pyridin-3-yl)ethanamine (Compound 14) is a tubulin polymerization inhibitor that can be used as an ADC payload .
loading...
    loading...
Cat. No.: HY-164706
CAS No.: 2369100-39-8
Research Areas:  

Cancer

m-PEG6-Lys-Mal-Toxophore-quinoline is a drug-linker conjugate for ADC and can be used for ADC synthesis. The payload is a NAMPT inhibitor (HY-164760) .
loading...
    loading...
Cat. No.: HY-164707
CAS No.: 2222981-66-8
Research Areas:  

Cancer

MC7 is a drug-linker conjugate that can be used in research related to ADC synthesis. The payload of MC7 is a NAMPT inhibitor (HY-402237).
loading...
    loading...
Cat. No.: HY-153909
Research Areas:  

Cancer

SMP-33693 is a Drug-Linker Conjugate for ADC with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
loading...
    loading...
Cat. No.: HY-153908
CAS No.: 3055605-39-2
Research Areas:  

Cancer

SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer .
loading...
    loading...
Cat. No.: HY-163672
CAS No.: 2688785-13-7
Glucocorticoid receptor modulator 3 (Payload 6) is a thioester-containing glucocorticoid receptor modulator (IC50=0.6 nM). Glucocorticoid receptor modulator 3 is designed to inactivate unconjugated payloads rapidly through liver metabolism, thereby minimizing systemic exposure. Glucocorticoid receptor modulator 3 can be utilized in the development of antibody-drug conjugates (ADCs) targeting autoimmune diseases .
loading...
    loading...
Cat. No.: HY-W800814
CAS No.: 2356229-77-9
Target:  

ADC Linkers

Research Areas:  

Cancer

Azido-PEG8-Amido-Val-Cit-PAB is a cleavable ADC linker. The Val-Cit will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell. Azido will react with DBCO, BCN or other alkyne groups through click chemistry. PEG spacer increases aqueous solubility. Reagent grade, for research purpose.
loading...
    loading...
Cat. No.: HY-W800621
CAS No.: 2055024-59-2
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-PEG2-Val-Cit-PAB-OH is an enzyme-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide. The benzylic alcohol on the PAB can be used to attach with reactive groups such as PNP for conjugation with drug payloads. The Fmoc protecting group may be removed with piperidine to reveal a primary amine for use in coupling reactions to form amides. The Val-Cit-PAB is cleaved by cellular proteases for efficient release of payloads to the cell.
loading...
    loading...
Cat. No.: HY-W800622
CAS No.: 2055024-58-1
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-PEG4-Val-Cit-PAB-OH is an enzyme-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide. The benzylic alcohol on the PAB can be used to attach with reactive groups such as PNP for conjugation with drug payloads. The Fmoc protecting group may be removed with piperidine to reveal a primary amine which may be used in coupling reactions to form amides. The Val-Cit-PAB is cleaved by cellular proteases for efficient release of payloads to the cell.
loading...
    loading...
Cat. No.: HY-W800623
CAS No.: 2055024-57-0
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-PEG6-Val-Cit-PAB-OH is an enzyme-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide. The benzylic alcohol on the PAB can be used to attach with reactive groups such as PNP for conjugation with drug payloads. The Fmoc protecting group may be removed with piperidine to reveal a primary amine which may be used in coupling reactions to form amides. The Val-Cit-PAB is cleaved by cellular proteases for efficient release of payloads to the cell.
loading...
    loading...
Cat. No.: HY-W800624
CAS No.: 2055024-55-8
Target:  

ADC Linkers

Research Areas:  

Cancer

Boc-PEG2-Val-Cit-PAB-OH is an enzyme-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide. The benzylic alcohol on the PAB can be used to attach with reactive groups such as PNP for conjugation with drug payloads. The Boc protecting group may be removed with acid to reveal a primary amine which may be used in coupling reactions to form amides. The Val-Cit-PAB is cleaved by cellular proteases for efficient release of payloads to the cell.
loading...
    loading...
Cat. No.: HY-W800625
CAS No.: 2055024-54-7
Target:  

ADC Linkers

Research Areas:  

Cancer

Boc-PEG4-Val-Cit-PAB-OH is an enzyme-cleavable ADC linker featuring a Boc-protected amine, a hydrophilic PEG spacer, and a Val-Cit-PAB dipeptide. The benzylic alcohol on the PAB can be used to attach with reactive groups such as PNP for conjugation with drug payloads. The Boc protecting group may be removed with acid to reveal a primary amine which may be used in coupling reactions to form amides. The Val-Cit-PAB is cleaved by cellular proteases for efficient release of payloads to the cell.
loading...
    loading...
Cat. No.: HY-176452
Research Areas:  

Cancer

NLRP3 agonist 3 (Compound Payload 5) is an antibody-drug conjugate (ADC). NLRP3 agonist 3 is a NLRP3 agonist that induces IL-1β secretion in primary human monocytes. NLRP3 agonist 3 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-167774
CAS No.: 1821304-87-3
Research Areas:  

Cancer

TLR7 agonist 32 (payload P3), a TLR7 agonist, is an ADC payload taht can be used in the synthesis of antibody-drug-conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-183254
CAS No.: 3053452-26-6
Research Areas:  

Others

MC-Gly-Gly-Phe-Gly-NH-CH₂-O-CH₂CO-homocamptothecin analog is a linker-payload conjugate, which can be used for the synthesis of ADCs.
loading...
    loading...
Cat. No.: HY-122715
CAS No.: 1971075-99-6
Research Areas:  

Cancer

(S,S)-D211 is a stereoisomer of D211. (S,S)-D211 belongs to PBD dimer family with DNA damage activity. (S,S)-D211 can be used as a cytotoxic payload for synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-176972
CAS No.: 3037777-07-1
Research Areas:  

Cancer

Di(MMY-SJG)-Ph-prop-2-yne-1-sulfonic acid (Compound 5) is a cytotoxic pyrrolobenzodiazepine (PBD) dimer derivative. Di(MMY-SJG)-Ph-prop-2-yne-1-sulfonic acid exhibits moderate DNA alkylating activity. Di(MMY-SJG)-Ph-prop-2-yne-1-sulfonic acid can be used as the payload of ADC, thereby demonstrating strong antigen-dependent cytotoxicity .
loading...
    loading...